Implementazione di un programma di controllo delle infezioni ospedaliere: un’analisi di costo ed efficacia

Journal title MECOSAN
Author/s Grazia Lomolino, Greta Falavigna, Roberto Ippoliti
Publishing Year 2014 Issue 2014/89
Language Italian Pages 28 P. 125-152 File size 967 KB
DOI 10.3280/MESA2014-089008
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

This study proposes a cost-effectiveness analysis concerning the implementation of a tool to check for Ventilator Associated Pneumonia (VAP) in Intensive Care. VAP is a sub-type of hospitalacquired pneumonia which occurs in people receiving mechanical ventilation. An empirical analysis is performed to estimate the effectiveness of a specific procedure to prevent VAP (i.e. Ventilator Bundle), as well as to evaluate cost savings related to not developing the infection. The relevance of the results thus obtained is not only clinical but also managerial and economic, since a reduction in costs improves the economic performance of hospitals and a lower incidence of VAP improves their reputation on the national market of healthcare services.

Keywords: Ventilator-associated pneumonia, ventilator bundle, cost-effectiveness analysis, intensive-care unit

  1. Aldeyab M.A., Elshibly S.M., McElnay J.C. (2009). An evaluation of compliance with an antibiotic policy in surgical wards at a general teaching hospital in Northern Ireland. Infection Control and Hospital Epidemiology, 30: 921-992. DOI: 10.1086/599308
  2. Augustine B. (2007). Ventilator-associated pneumonia: risk factors and prevention. Critical Care Nurse, 27 (4): 32-39.
  3. Bellini R., Bonelli G., Giorgione N. (2010). Le indagini di soddisfazione del paziente come strumento di governance nelle aziende sanitarie. Mecosan, 75: 77-89.
  4. Berriel-Cass D., Adkins F.W., Jones P., Fakih M.G. (2006). Eliminating nosocomial infections at Ascension Health. Joint Commission Journal on Quality & Patient Safety, 32 (11): 612-620.
  5. Boaretto G., De Silvestri A., Klersy C., Gasparini C., Gramegna L., Scaboro G., Tomasi L., Tomasi C., Tomei R., Zanon F. (2012). Follow-up dei dispositivi cardiaci impiantabili: analisi dei costi socio-economici. Mecosan, 81: 87-104.
  6. Burger C.D., Resar R.K. (2006). Ventilator bundle approach to prevention of ventilator-associated pneumonia. Mayo Clinic Proceedings, 81 (6): 849-850. DOI: 10.4065/81.6.849
  7. Calamandrei C. (2000). La soddisfazione degli infermieri in relazione alla soddisfazione dei pazienti. Management infermieristico, 3: 26-32.
  8. Canitano S., Ghirardini A., Migliazza M., Trinchero E. (2010). Risk management, strumenti e cultura organizzativa per il governo della patient safety: dalla teoria alla pratica. Mecosan, 76: 89-108.
  9. Cason C.L., Tyner T., Saunders S., Broome L. (2007). Nurses’ Implementation of guidelines for ventilator-associated pneumonia from the Center for Disease Control and Prevention. American Journal of Critical Care, 16 (1): 28-37.
  10. Chao-Ying J. Peng, Kuk L. Lee, Ingersoll G.M. (2002). An Introduction to Logistic Regression Analysis and Reporting. The Journal of Educational Research, 96, 1: 3-14, DOI: 10.1080/00220670209598786
  11. Chastre J., Fagon J.Y. (2002). Ventilator-associated pneumonia. American Journal of Respiratory and Critical Care Medicine, 165: 876-903. DOI: 10.1164/ajrc.165.7.2105078
  12. Cocanour C.S., Peninger M., Domonoske B.D., Li T., Wright B., Valdivia A., Luther K.M. (2006). Decreasing ventilator-associated pneumonia in a trauma ICU. Journal of Trauma-Injury Infection & Critical Care, 61 (1): 122-129. DOI: 10.1097/01.ta.0000223971.25845.b3
  13. Coello R., Glenister H., Fereres J. et al. (1993). The cost of infection in surgical patients: a case control study. Journal of Hospital Infection, 26: 239-250. DOI: 10.1016/0195-6701(93)90110-I
  14. Davis K.A. (2006). Ventilator-associated pneumonia: a review. Journal of Intensive Care Medicine, 21 (4): 211-226. DOI: 10.1177/0885066606288837
  15. Del Vecchio M., Cosmi L. (2003). Il risk management nelle aziende sanitarie. Milano: MCGraw-Hill.
  16. De Santo L.S, Bancone C., Santarpino G., Romano G., De Feo M., Scardone M., Galdieri N., Cotrufo
  17. M. (2008). Microbiologically documented nosocomial infections after cardiac surgery: an 18-month prospective tertiary care centre report. European Journal of Cardio-thoracic Surgery, 33 (4): 666-672. DOI: 10.1016/j.ejcts.2007.12.046
  18. Gadani H., Vyas A., Kar A.K. (2010). A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian Journal of Anaesthesia, 54 (6): 535-540. DOI: 10.4103/0019
  19. Giacomelli G., Longo F. (2012). La mobilità internazionale dei pazienti nella EU: determinanti, rilevanza, regole e tendenze. Mecosan, 81: 105-117.
  20. Girard R., Fabry J., Meynet R., Lambert D.C., Sepetjan M. (1983). Costs of nosocomial infection in a neonatal unit. Journal of Infectious Diseases, 4: 361-366. DOI: 10.1016/0195-6701(83)9006-3
  21. Greene W.H. (2008). Econometric Analysis, 6th ed. Upper Saddle River, NJ: Pearson Prentice Hall.
  22. Griffin F.A. (2007). 5 Million Lives Campaign. Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections. Joint Commission Journal on Quality & Patient Safety, 33 (12): 726-731.
  23. Haley R.W. (1991). Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital. The American Journal of Medicine, 91 (3): s32-s38. DOI: 10.1016/0002-9343(91)90341-t
  24. Haley R.W., Schaberg D., Crossley K., Von Allmen S., McGowan J. (1981). Extra charges and prolongation of stay attributable to nosocomial infections: a prospective inter-hospital comparison. American Journal of Medicine, 70: 51-58. DOI: 10.1016/0002-9343(81)9041-3
  25. Hall C. (2000). 5000 patients a year killed by infections in hospital. The Telegraph, 17 February.
  26. Hampton D., Norton J. (2006). A model for quantifying quality initiatives in intensive care. Journal of Nursing Care Quality, 21 (1): 70-77. DOI: 10.1097/00001786-200601000-00014
  27. Ibrahim E.H. (2001). The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest, 120 (2): 555-61. DOI: 10.1378/chest.120.2.555
  28. Ippoliti R., Falavigna G. (2012). Efficiency of medical care industry: evidence from the Italian regional system. European Journal of Operational Research, 217: 643-652. DOI: 10.1016/j.ejor.2011.10.010
  29. Ippoliti R., Falavigna G. (2013). Subjects’ decision making process: an empirical analysis on patients’ mobility process and the role of pharmaceutical clinical research. International Review of Economics, 60 (3): 319-342. DOI: 10.1007/s12232-012-0167-8
  30. Kappstein I., Schulgen G., Fraedrich G., Schlosser V., Schumacher M., Daschner F.D. (1992). Added hospital stay due to wound infections following cardiac surgery. The Thoracic and Cardiovascular Surgeon, 40: 148-151. DOI: 10.1055/s-2007-1020134
  31. Koenig S.M., Truwit J.D. (2006). Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clinical Microbiological Reviews, 19 (4): 637-657. DOI: 10.1128/cmr.0051-05
  32. McManus M.L., Berwick D.M. (2003). Variability in Surgical Caseload and Access to Intensive Care Services. Anaesthesiology, 98 (6): 1491-1496. DOI: 10.1097/00000542-2003060000-00029
  33. Mugford M., Kingston J., Chalmers I. (1989). Reducing the incidence of infection after Caesarian section: implications of prophylaxis with antibiotics for hospital resources. British Medical Journal, 299: 1003-1006. DOI: 10.1136/bmj.299.6706.1003
  34. Murray I. (1997). Hospital infections kill thousands. The Times, 16 September: 4. National Nosocomial Infections Survelliance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control, 32: 470-485. DOI: 10.1016/j.ajic.2004.10.001
  35. Nichelatti M., Lomolino G., Montomoli C. (2007). Nosocomial infections in an Italian hospital: prevalence and risk factors. Biomedical Statistics and Clinical Epidemiology, 1 (1): 39-45.
  36. Pellicelli G. (1999). Il marketing. Torino: Utet.
  37. Peng C.Y.J., Lee K.L., Ingersoll G.M. (2002), An Introduction to Logistic Regression Analysis and Reporting. The Journal of Educational Research, 96 (1): 3-14. DOI: 10.1080/00220670209598786
  38. Plowman R., Graves N., Griffin M., Roberts J.A., Swan A., Cookson B., et al. (2000). The socio-economic burden of hospital acquired infection. London: PHLS. (executive summary:
  39. Rabe-Hesketh S., Everit B. (2004). A handbook of statistical analyses using STATA, Third Edition. CRC Press LLC.
  40. Rello J., Ollendorf D.A., Oster G., Vera-LIonch M., Bellm L., Redman R., Kollef M.H.; VAP Outcomes Scientific Advisory Group (2002). Epidemiology and oucomes of ventilated-associated pneumonia in a large US database. Chest, 122: 2115-2121. DOI: 10.1378/chest.122.6.2115
  41. Resar R., Pronovost P., Haraden C., Simmonds T., Rainey T., Nolan T. (2005). Using a bundle approach to improbe ventilator care processes and reduce ventilator-associated pneumonia. Joint Commission Journal on Quality & Patient Safety, 31 (5): 243-248.
  42. Theban O.C., Anderson L.J., Besser R., Bridges C., Hajjeh R. (2004). Guidelines for preventing Health-Care-Associated Pneumonia, 2003 – Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee, Recommendations and Reports, 53(3):1-36, Mar.
  43. Tolentino-DelosReyes A.F., Ruppert S.D., Shiao S.Y. (2007). Evidence-based practice: use of the
  44. ventilator bundle to prevent ventilator-associated pneumonia. American Journal of Critical Care, 16 (1): 20-7.
  45. Tuhina B., Shampa A., Dinesh K.S. (2013). Poor compliance with the antibiotic policy in the intensive care unit (ICU) of a tertiary care hospital in India. Journal of Infection in Developed Countries, 7 (12): 994-998. DOI: 10.3855/jidc.3077
  46. Wilcox M.H., Cunniffe J.G., Trundle C., Redpath C. (1996). Financial burden of hospital-acquired Clostridium difficile infection. Journal of Hospital Infection, 34: 23-30. DOI: 10.1016/s0195-6701(96)90122-x
  47. Wilcox M.H, Dave J. (2000). The cost of hospitalacquired infection and the value of infection control. Journal of Hospital Infection, 45: 81-84. DOI: 10.1053/jhin.2000.0792
  48. Youngquist P., Carroll M., Farber M., et al. (2007). Implementing a ventilator bundle in a community hospital. Joint Commission Journal on Quality and Patient Safety. 33 (4): 219-25.
  49. Zoutman R., McDonald S., Vethanayagan D. (1998). Total and attributable costs of surgicalwound infections at a Canadian tertiary-care center. Infection Control and Hospital Epidemiology, 19: 254-259. DOI: 10.1086/647804

Grazia Lomolino, Greta Falavigna, Roberto Ippoliti, Implementazione di un programma di controllo delle infezioni ospedaliere: un’analisi di costo ed efficacia in "MECOSAN" 89/2014, pp 125-152, DOI: 10.3280/MESA2014-089008